FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management
Year: 2023
Type: article
Source: JAMA
Author: Jennifer Abbasi
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4388695162
